Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 19,269	$ 25,802
Short-term investments	31,410	33,481
Accounts receivable, net	78,736	78,881
Inventory, net	56,932	53,160
Prepaid expenses and other current assets	26,494	17,690
Total current assets	212,841	209,014
Property and equipment, net	14,537	14,863
Right-of-use lease assets	2,091	2,787
Other assets	6,283	6,483
Total assets	235,752	233,147
Current liabilities:
Accounts payable	12,333	11,709
Accrued clinical and manufacturing liabilities	20,060	25,402
Accrued payroll and employee liabilities	6,451	9,554
Other accrued liabilities	47,423	41,755
Current lease liabilities	2,290	3,037
Total current liabilities	88,557	91,457
Non-current notes payable, net	25,213	25,026
Non-current convertible notes payable, net	149,753	149,700
Other non-current liabilities	682	615
Total liabilities	264,205	266,798
Stockholders' deficit:
Common stock	1,524	1,521
Additional paid-in capital	1,886,981	1,884,409
Accumulated other comprehensive income	1	13
Accumulated deficit	(1,916,959)	(1,919,594)
Total stockholders' deficit	(28,453)	(33,651)
Total liabilities and stockholders' deficit	$ 235,752	$ 233,147